The legal fight over mifepristone has entered yet another volatile phase.  In early May 2026, the 5th U.S. Circuit Court of Appeals ruled that mifepristone must be dispensed in person, effectively blocking telehealth prescribing and mail delivery nationwide. That decision would have upended a system that, since 2021, has allowed patients to access the drug…